Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study-Reference-Cited by-同舟云学术

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Published:2013-01 Issue:9860 Volume:381 Page:40-46
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cuchel Marina,Meagher Emma A,du Toit Theron Hendrik,Blom Dirk J,Marais A David,Hegele Robert A,Averna Maurizio R,Sirtori Cesare R,Shah Prediman K,Gaudet Daniel,Stefanutti Claudia,Vigna Giovanni B,Du Plessis Anna ME,Propert Kathleen J,Sasiela William J,Bloedon LeAnne T,Rader Daniel J

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment;Rader;J Clin Invest,2003

2. Familial hypercholesterolemia;Goldstein,2001

3. Homozygous familial hypercholesterolaemia;Macchiaiolo;Lancet,2012

4. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia;Kolansky;Am J Cardiol,2008

5. Homozygous familial hypercholesterolemia and its management;Marais;Semin Vasc Med,2004

Cited by 643 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases;IJC Heart & Vasculature;2024-08

2. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA);Nutrition, Metabolism and Cardiovascular Diseases;2024-08

3. Reply to Blom: Drugs Do Not Work in Patients Who Cannot Tolerate Them;Global Journal on Quality and Safety in Healthcare;2024-08-01

4. Letter in Response to “Lomitapide: A Medication Use Evaluation and a Formulary Perspective” by Esba and Alharbi;Global Journal on Quality and Safety in Healthcare;2024-08-01

5. Consenso sobre lipoproteína (a) de la Sociedad Española de Arteriosclerosis. Revisión bibliográfica y recomendaciones para la práctica clínica;Clínica e Investigación en Arteriosclerosis;2024-07